Pricing

LadRx Corp (LADX)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Stephen Snowdy
Employees:
3
11726 SAN VICENTE BOULEVARD, SUITE 650, LOS ANGELES, CA, 90049
310-826-5648
Stock Split History
DateRatio
2012-05-16 1:7
2017-11-01 1:6
CytRx Corporation focuses on oncology and rare diseases. It engages in the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies. The company's lead candidates include linker activated drug release (LADR) -7, LADR-8,. and Aldoxorubicin that binds to circulating albumin in the bloodstream and to concentrate the drug at the site of the tumor.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available